DK Street Journal

Norfolk Southern's executives spent part of their 23 July earnings call describing conditions on somebody else's network. A freight downturn four years old was "finally breaking," they said, and the proof was that about 15% of contracted truckload shipments were being turned down by carriers — a multiyear high — with rejections on flatbed trailers, the open decks that haul transformers, structural steel and switchgear, running near 40%. The railroad also reported a 30% year-over-year increase in transformer shipments, and said its pipeline of new customer facilities along the line should nearly double this year, including a Virginia Transformer plant in Alabama.

The truckers then confirmed it with their own numbers, and their shares fell anyway.

The best quarter of the cycle

All four road-freight names in this group posted their strongest quarter since the downturn began and lifted full-year guidance. Old Dominion Freight Line, the largest less-than-truckload (LTL) carrier — the business of consolidating pallet-sized shipments from many customers into one trailer, run here from roughly 250 service centers — grew revenue 10.4% and operating income 30.0%, cutting its operating ratio, the share of revenue eaten by expenses, to 70.1%. XPO, which pairs a North American LTL network with a freight brokerage, hit a company-record 79.9% LTL operating ratio and raised its full-year improvement target from 100–150 basis points to at least 200; July shipments per day were tracking up 6%, which management called the first sign of manufacturing momentum in more than three years.

Saia, a smaller LTL carrier moving shipments of 100 to 10,000 pounds out of 213 terminals, reported record revenue of $956.5m, up 17.1%, with tonnage per day up 8.4% and a 7.1% general rate increase implemented in early July. J.B. Hunt, the largest domestic intermodal operator — containers on railroad flatcars, trucked the final miles — moved more than 578,000 loads, up 10%, with the Eastern network up 16% and revenue per load positive excluding fuel for the first time since 2022.

Over the past month Saia lost 12.3%, Old Dominion 11.0%, J.B. Hunt 6.3% and XPO 3.8%. The railroads lost between 1.1% and 1.9%.

How much of it was diesel

The caveat sits inside the revenue line. Brent crude went from about $70 a barrel to above $100 after the Iran conflict began, and US average diesel reached roughly $5.40 a gallon. Union Pacific disclosed that fuel surcharges alone supplied 750 basis points of its freight-revenue growth, against 225 from volume. Saia's fuel take was 22.3% of revenue against 14.6% a year earlier; strip it out and revenue per shipment rose 1.5%. Old Dominion is the cleanest case: revenue per hundredweight up 15.2% reported, 5.5% ex-fuel, and tons per day still down 4.1%. Its margin surge came from price and cost, not from more freight. Industry data agrees that the tightening is supply-side — spot rates ex-fuel up 43% in June while shipment counts fell.

The rails have the corroboration

CSX, the eastern railroad with about 19,500 route miles and some 30 intermodal terminals, grew volume 6% and expanded operating margin 240 basis points despite a fuel headwind, raising full-year guidance to more than 350 basis points of margin expansion and over 80% free-cash-flow growth. Union Pacific, whose 32,452 route miles link the Pacific and Gulf ports to Midwest gateways, ran a 59.2% operating ratio and raised earnings guidance. Norfolk Southern grew volume 4% but pushed its 2026 operating-expense guidance up by roughly $500m on fuel. Industry figures back the volume claim: US carloads are up 2.7% and intermodal 3.8% through the first 31 weeks of the year.

The Union Pacific–Norfolk Southern merger is not doing this work. The Surface Transportation Board accepted the application but held proceedings in abeyance, demanding supplemental information; the case is evidentiary, not close to approval. CSX has held an uptrend, its 50-day average above its 200-day, for 80 straight sessions since 17 April.

What each dollar of profit costs

The railroads are the cheapest operating profit in the group on enterprise value to earnings before interest, taxes, depreciation and amortization (EBITDA) — Union Pacific 15.3x, CSX 16.6x, Norfolk Southern 16.7x — with forward price/earnings below trailing at all three and free-cash-flow yields of 5.4% at CSX and 5.1% at Norfolk Southern.

Old Dominion at 24.0x and XPO at 22.1x EBITDA, on cash yields of 2.5% and 2.4%, are being marked down from expensive. Saia at 16.5x and J.B. Hunt at 16.7x are the anomaly: rail multiples on operating income growing 26.0% and 31.5%, against Union Pacific's 9.7%. Their identifiable catalysts are not operational. Amazon's June move to open LTL shipping to all businesses knocked LTL stocks 5–7% in a session, and Morgan Stanley's downgrade of J.B. Hunt cited valuation after an 89% year, not the business.

One discipline check: strip each company's two best sessions from the past year and Saia's gain falls from 25.9% to 5.2%, Norfolk Southern's from 18.4% to 6.5%. WillScot, which leases modular offices and portable storage to construction sites and is not a freight carrier at all, goes from -3.6% to -28.8% — even as it raised guidance to about $2.3bn of revenue and $920m of EBITDA and carries a 12.5% cash yield on margins that compressed 500 basis points.

The setup

Where it stands — Road freight posted its best quarter of the cycle and de-rated; the rails, cheaper and volume-corroborated, held. Would confirm — Old Dominion tons per day turning positive year over year in the third quarter. Would invalidate — Diesel retreating toward $4 a gallon and LTL revenue growth collapsing with it. Watch next — Third-quarter results in late October, plus weekly rail traffic from the Association of American Railroads. Valuation — Rails 15.3–16.7x trailing EBITDA with forward P/E under trailing; Saia and J.B. Hunt now match them at 16.5x and 16.7x.

BioNTech, the Mainz company that made the COVID-19 vaccine sold with Pfizer, told investors on 4 August that it now expects 2026 revenue of €1.6-1.9bn, down from the €2.0-2.3bn it guided to in March. Roughly 80% of the cut was softer global COVID demand; Germany, management said, will work through doses it already holds this season. Second-quarter revenue fell 59.5% to about $122m, gross margin collapsed to 8.1% from 70.7% a year earlier, and the operating loss ran past $1bn.

The company is also, by one measure, barely a business at all in the market's eyes: it ended the quarter with €16.6bn of cash against a $23.4bn market capitalisation. Guido Oelkers takes over as chief executive from founder Ugur Sahin by 1 February.

The three that ship doses

Novavax, the Maryland maker of a protein-based COVID vaccine now commercialised by Sanofi, reported second-quarter revenue of $57m against $239m a year earlier, a 76% decline, and a $53m net loss. That followed a 79% decline in the first quarter. Consensus has revenue falling another 63% this year to $389m, then 30% again in 2027.

Valneva, the French specialty vaccine maker behind travel shots for Japanese encephalitis, cholera and chikungunya, has now posted four consecutive quarters of falling revenue. Second-quarter gross profit dropped 93% to about $2m as failed batches hit margins and its chikungunya vaccine carried nearly $11m of manufacturing cancellation fees. On its 13 August call management said the path to self-sustainability is "all about Lyme" — the vaccine it is developing with Pfizer.

The next day Valneva shares rose 29.0%, after the European Medicines Agency validated the Lyme filing on Phase 3 efficacy above 70%. Validation means the agency has accepted the dossier for review. It is not an approval and it ships nothing.

The three that rose

Vaxcyte, a California developer of pneumococcal conjugate vaccines, is the group's cleanest riser: up 84.8% over twelve months, with a best single day of just 7.2%. It has also reported zero revenue in every quarter and every year on record back to 2021, burned $303m in the June quarter alone, and carries a free-cash-flow yield of minus 14.3% — roughly a seventh of its market value in cash each year. Its adult and infant trials are fully enrolled, with the first Phase 3 topline due in the fourth quarter. The entire move has been made ahead of any Phase 3 data. The user's own notes flag it as one of seven small- and mid-cap biotechs named in a July Barron's roundtable as a plausible takeout candidate.

Abivax, a Paris company with 80 employees and an $8.7bn market value, is not a vaccine business at all. Its lead asset is an oral drug for ulcerative colitis, and both doses met the primary endpoint in a Phase 3 maintenance trial reported on 1 June. The shares fell 44.1% on 2 June, rose 24.3% the next session and 38.6% on 30 June. A filing with the US Food and Drug Administration is planned for late in the fourth quarter.

Vir Biotechnology, built on COVID and hepatitis-delta antibodies, booked $239m of second-quarter revenue and an $80m profit from one event: Astellas paid $240m upfront plus $75m of equity for a prostate-cancer drug. The prior quarter's revenue was minus $29,000. Consensus has 2027 revenue down 57% once the payments roll off.

What the average hides

Remove each name's two best sessions of the past year and the group's average return falls from 34.0% to minus 4.0%, with the median at minus 16.4%. The S&P 500 tracker returned 20.4%. Over the past six months the six averaged minus 3.8% against the index's 13.9%, so the year was earned before February. The 30-day gain is Valneva's single session; the other five average minus 2.9%.

On valuation there is no split at all. Every member's forward multiple sits above its trailing one — BioNTech at 7.51x trailing sales against 12.29x forward, Vir 5.14x against 7.02x, Valneva 3.98x against 4.37x, Novavax 3.20x against 3.40x. The shrinking names got more expensive per dollar of revenue as they fell, because revenue fell faster. Vaxcyte prices at 335x forward sales, Abivax at more than 2,000x.

Only Abivax trades with its 50-day average clearly above its 200-day; BioNTech's has rolled under, and three sit flat. The policy backdrop has not helped: the US Health and Human Services Secretary replaced the CDC's vaccine advisory panel in 2025, a childhood schedule approved outside the usual process was stayed by a federal court in March, and the committee's charter was rewritten in April. Moderna, outside this group, is up 137% over twelve months on flu-vaccine progress. These six did not participate.

The setup

Where it stands — Every dollar of this group's twelve-month gain came from companies with no commercial product; the three with products are shrinking. Would confirm — Vaxcyte's fourth-quarter Phase 3 topline hits its primary endpoint, giving the $8.4bn valuation its first commercial anchor. Would invalidate — BioNTech lands 2026 revenue at or above the €1.9bn top of guidance, ending the COVID franchise's decline. Watch next — Vaxcyte OPUS-1 and Vir ECLIPSE 1 toplines, both due in the fourth quarter of 2026. Valuation — BioNTech 7.51x trailing sales rising to 12.29x forward; Valneva 24.3x trailing gross profit rising to 26.7x.

The closure of the Strait of Hormuz has taken more than 10 billion cubic feet a day of liquefied natural gas off the world market, about a fifth of global supply, most of it Qatari volumes from Ras Laffan. Asian spot cargoes were assessed at $21.19 per million British thermal units (MMBtu) on 11 August. The American natural gas that feeds U.S. export plants went the other way, front-month Henry Hub falling 4.4% over the past 30 days to $2.73.

That gap is not, however, what U.S. exporters actually sell. Their long-term contracts are built as a fixed liquefaction fee of roughly $2.25-3.50/MMBtu plus about 115% of Henry Hub for the gas itself. Those fees are flat — Cheniere is guiding new Sabine Pass expansion deals at $2.50-3.00, NextDecade at "north of $2.50 but south of $3." So the only question that matters for the past month's advance is who keeps the spread, and who merely collects a toll while it widens.

The toll collectors

Cheniere Energy, which owns and operates the Sabine Pass and Corpus Christi terminals and markets the gas, is the toll. Management said in August that a $1 change in market margins moves full-year earnings before interest, taxes, depreciation and amortization (EBITDA) by less than $50m, with under 1 million tonnes unsold for 2026. Its quarter was still strong on volume: revenue rose 26.3% year over year to $5.73bn, production rose 20%, and guidance was raised for a second consecutive quarter, to $7.90-8.40bn of EBITDA from $7.25-7.75bn. Corpus Christi Stage 3 was 98.4% complete at the end of June, running ahead of its guaranteed 2027 date. Cheniere bought back 5m shares for $1.1bn in the first half, cutting the diluted count 5.8%.

The price has moved faster than that. Cheniere trades at 10.0x trailing EV/EBITDA, against the roughly 7.3x recorded in May — a multiple expansion of about a third on a business whose contracted fees did not change. A forward earnings multiple is not usable here: consensus 2026 earnings per share are -$6.62 because of derivative marking, the same accounting that produced a $3.5bn net loss in the first quarter and a 74.8% operating margin in the second.

Cheniere Energy Partners, the master limited partnership that holds Sabine Pass, is the harder case. It was the best performer of the four, up 11.0% over 30 days across 13 of 23 sessions — a broad advance, not one headline day. The business did not keep pace. Revenue growth decelerated to 5.2% year over year from 20.4% the prior quarter, and the partnership reconfirmed rather than raised full-year distribution guidance of $3.10-3.40 per unit. Consensus has revenue falling 3.2% in 2027 and rising 4.3% in 2028; the next real step is 2029, when the Train 7 expansion signed with Bechtel arrives. It is the dearest name in the group on every lens available: 11.26x trailing EV/EBITDA, 7.80x price-to-gross-profit against Cheniere's 4.83x, and roughly $1.11bn of market value per million tonnes a year of operating capacity.

The spread taker

Venture Global, which builds and runs the Calcasieu Pass and Plaquemines plants on the Gulf Coast, is the opposite structure. Its raised guidance of $8.7-9.1bn of EBITDA rests explicitly on a $12.50-13.50/MMBtu market liquefaction fee, and a $1 move is worth $180m-210m this year and $650m-700m in 2027. Revenue rose 47.6% to $4.58bn and operating margin widened to 47.2% from 33.5%. It signed over 2 million tonnes a year of new offtake with TotalEnergies, Vitol, EnBW and Atlantic-SEE, lifting its 2026 contracted position to 91% from 84%, while deliberately pivoting new capacity toward three-to-five-year deals that price at roughly twice 20-year rates.

It is also the cheapest — 10.3x trailing earnings falling to 9.2x forward, 4.40x EV/EBITDA — and it carries the group's one large unresolved liability. BP has won the liability phase of its arbitration over Calcasieu Pass and seeks damages above $1bn; the next hearing is in late November. Free cash flow is running at -27.5% of market value as Plaquemines and CP2 are built at once. Consensus expects revenue to fall 12.6% in 2027. Notably, the shares fell 5.2% on 11 August, the day the guidance was raised.

The one being marked down

NextDecade, building the Rio Grande terminal near Brownsville, Texas, has fallen 5.5% in a month, 21.2% in a quarter and 27.9% in a year — and none of it is a construction problem. Trains 1-2 are 74% complete, Train 3 past half, first LNG is due in the first half of 2027, and the second-quarter loss of $0.25 a share beat a $0.62 consensus. What is being marked is the claim, not the plant: zero revenue, a $65.4m quarterly net loss, negative book value, an equity entitled to only about 20.8% of Phase 1 distributions until an investor return hurdle clears, and 6.06x forward price-to-sales against Venture Global's 1.88x.

The setup

Where it stands — A spot-price spike has lifted three operating exporters whose long-term fees are unchanged, and left the pre-revenue builder behind. Would confirm — Cheniere Partners raising, not reconfirming, its $3.10-3.40 distribution guidance at the third-quarter report. Would invalidate — Asian spot prices returning toward $12/MMBtu, which would remove the earnings upgrades Venture Global's guidance is built on. Watch next — The BP damages hearing on Calcasieu Pass, scheduled for late November 2026. Valuation — Cheniere Partners at 11.5x trailing earnings and 17.6x forward; Venture Global 10.3x falling to 9.2x; Cheniere 10.0x EV/EBITDA versus about 7.3x in May.

Four of the eight big listed firms that sell corporate technology work — building software, running back offices, staffing projects — cut their full-year revenue forecasts this summer. One raised its profit forecast. Between mid-July and mid-August the shares of all eight went up together, by about 20% on average, and the size of each move bore almost no relation to which side of that line the company was on.

The two biggest gainers, Cognizant and Accenture, are the two with the better delivered numbers, yet both still sit below their longer-run averages after brutal falls earlier this year. Accenture traded as high as $288.54 in 2026 and as low as $124.44 — a 57% peak-to-trough drop — so even a 31% bounce leaves its trend measures pointing down. That is arithmetic about how far each fell, not a judgment on any of these businesses.

Who actually delivered

Cognizant, a New Jersey outsourcer with 356,700 employees running technology and business processes for banks, insurers and healthcare firms, is the one that raised. On 29 July it lifted 2026 adjusted earnings guidance to $5.70–$5.82 a share, from a prior 7–9% growth range, reporting revenue up 4.5% to $5.48bn. Trailing bookings reached $29bn, up 5%, with seven deals above $100m of contract value. It bought back $1.1bn of stock in the quarter and is on pace for roughly $2.6bn this year — more than a tenth of its market value.

Accenture, the Dublin-headquartered consultancy employing 799,000 people, grew revenue 5.6% to $18.72bn in the quarter to 31 May, with operating income up 6.5% and margin steady at 17.0%. Its trailing free-cash-flow yield of 11.6% is the highest of the eight. The blemish is the order book: bookings fell 2%, and it trimmed its revenue outlook.

CGI, the Montreal IT and business-process firm with 94,000 staff serving governments, banks and utilities, is the outlier on hiring — recruitment is up 50% year on year while most peers shrink. Revenue rose only 2.5% to $4.19bn and organic growth was roughly zero once acquisitions are stripped out, but it booked $4.2bn in the quarter and closed with backlog of $31.8bn, about 1.9 times annual revenue. Management says it sees no broad pullback in discretionary spending.

Grid Dynamics, a San Ramon engineering shop of 4,838 people building digital platforms for Fortune 1000 retailers and telecoms, grew revenue 7% to $108.2m with gross profit up 14.8% — the fastest in the group — and raised third-quarter guidance. Work it classes as AI passed 30% of revenue. It did that while cutting headcount 3%.

Who did not

EPAM, the Pennsylvania software-engineering firm with 62,850 staff, showed the cleanest operating leverage of the eight: revenue up 4.5%, gross profit up 10.3%, operating income up 20.4%. Then on 6 August it cut full-year revenue growth to 3.2–4.2%, with Americas revenue up just 0.5% against Europe's 10.9%, and pushed its large-deal pipeline into 2027. The shares fell 14.5% that session and still finished the month higher.

Globant, the Luxembourg-domiciled builder of AI-integrated software with 28,510 employees, reported revenue of $614.4m, flat year on year, with gross profit down 4.3% and net income of $1.8m. It reduced full-year revenue guidance to $2.43bn–$2.46bn, blaming Saudi budget cuts, weak travel spending and slower North American decisions. Its own AI product line is running at $52.8m of annualized revenue, about 2% of the total.

Infosys, the Bengaluru firm with 328,062 employees, cut fiscal 2027 constant-currency guidance to 1.5–3.0% growth — roughly half a point organic once acquisitions are excluded — and management confirmed outright pricing "deflation" on renewals, with clients now demanding productivity savings mid-contract. It is nonetheless hiring 20,000 graduates. Wipro, its 240,000-employee neighbor, reported IT services revenue of $2.61bn, down 1.2% from the prior quarter, and guided to another sequential decline, with margin off 120 basis points to 16%.

This is not company-specific. HCLTech's leadership sees 2–3% annual price deflation in traditional services, and the industry body NASSCOM's president Rajesh Nambiar has put it plainly: "A headcount-based model assumes that value scales with effort, but AI fundamentally challenges that premise."

What the prices assume

Because gross margins here run from 16% at CGI to 37% at Grid Dynamics, price-to-sales tells you little; price per dollar of trailing gross profit is comparable. On that measure the order is Globant 2.04x, EPAM 3.30x, Cognizant 3.82x, Grid Dynamics 4.29x, Accenture 4.63x, CGI 6.50x, Wipro 6.60x and Infosys 8.07x. The firm that raised guidance is third-cheapest; the firm conceding price cuts is the most expensive, and also trades at 5.18x book against Globant's 0.76x.

Infosys is the only one of the eight whose forward earnings multiple (15.2x) exceeds its trailing (14.9x) — consensus expects earnings to go nowhere. EPAM has the widest gap the other way, 13.6x trailing against 7.7x forward. Accenture's 12.8x forward compares with a five-year year-end range of 21x to 37x. Grid Dynamics is the expensive one: 14.4x trailing EV/EBITDA against 6.4x–9.7x for the rest, on quarterly operating income of $1.28m.

Seven of the eight are still cheaper per dollar of gross profit than in mid-February; only Grid Dynamics has re-rated upward, and it is the only member trading above its 200-day average. Seven recorded their single best session between 27 and 30 July, when a selloff in chip stocks pushed money toward firms that build no AI hardware. Strip each name's two largest sessions and the 20% month becomes 0.3%.

The setup

Where it stands — Eight IT services firms rallied together in a rotation; only Cognizant, CGI and Grid Dynamics reported businesses that improved. Would confirm — Cognizant delivering full-year adjusted earnings within $5.70–$5.82 with a seventh straight quarter of margin expansion. Would invalidate — Cognizant or Accenture bookings turning negative year on year, putting the guidance raise beyond reach. Watch next — Accenture's fiscal fourth-quarter results in late September, the first read on whether bookings stop shrinking. Valuation — Cognizant 12.6x trailing and 10.2x forward earnings; Infosys 14.9x trailing versus 15.2x forward, the only inversion of the eight.

BWX Technologies is the only company cleared to build the reactors that propel American submarines and aircraft carriers. On 3 August it reported a June quarter with revenue of $901.6m, up 18% from a year earlier, the fourth straight quarter of growth between 18% and 29%. Backlog reached $8.4bn, up 40%, on a trailing book-to-bill of 1.7x — for every dollar of work delivered, it booked $1.70 of new orders. Management raised full-year guidance to roughly $3.8bn of revenue and $4.70-$4.80 of adjusted earnings per share, and agreed to sell just over 80% of its medical isotope business to Nordic Capital for up to $800m.

The shares fell after hours, with reporting attributing the reaction to a small revenue miss and higher spending plans. Over the past month BWXT is down about 2%, while seven of the eight other companies that mine, enrich or design nuclear fuel and reactors rose. It is the only one whose numbers unambiguously improved.

The month was four days

Equally weighted, the nine names gained 9.5% over 30 days. They are down 16.5% over 90 days, 23.2% over 180 and 12.6% over twelve months, and every one of them sits between 27% and 82% below its 52-week high. Remove each company's two largest single sessions from the last 21 trading days and the average return flips from +3.9% to -3.4%, with eight of the nine negative.

The same four dates — 21 and 30 July, 3 and 7 August — supplied the best days for essentially every name. The largest, 30 July, was a sector event, not a company one: the Nuclear Regulatory Commission accepted Holtec International's plan to build four small modular reactors totaling 1.36 gigawatts at the retired Oyster Creek site, and data-center operator Crusoe announced a partnership with reactor developer Aalo Atomic. The Global X Uranium ETF did the same thing, up 9.9% over 30 days and down 10.0% over 90. Much of the gain is a round trip out of a late-July drawdown that included three shared down days of 5% or worse.

The commodity gives two answers

The uranium price that appears on screens has gone nowhere. Spot U3O8 was $86.48 per pound on 8 August, against $86.95 at the end of February and a January peak above $101. Contracted prices, which is what producers actually get paid, tell the opposite story: TradeTech's long-term indicator reached $93.00 per pound on 31 March, the highest in more than 18 years. Cameco told its 31 July call that long-term prices are in the mid-90s and tracking toward $100, with market-related contract floors in the high 70s and ceilings near $160.

Cameco: the de-rating is doing its job

Cameco mines and mills uranium and, through its fuel services arm, converts it into reactor fuel. Its June quarter was poor: revenue fell 7.2% to $814.1m, gross margin fell to 21.1% from 29.3%, and net income fell 92% to $25.2m. It holds contracts for more than 28 million pounds of average annual deliveries and left 2026 production guidance unchanged at 19.5-21.5 million pounds.

The stock trades at 165.8x trailing and 59.6x forward earnings. That forward figure is higher than the roughly 56x recorded in this desk's May notes, despite a 13% six-month decline — estimates fell faster than the price. The bull case rests on Westinghouse, 49% owned by Cameco, which has filed to go public; the Department of Energy committed $17.5bn of conditional financing in June for long-lead AP1000 reactor components. Those units enter service in 2033-2034.

Centrus: real backlog, shrinking earnings

Centrus Energy sells separative work units — the measure of enrichment effort — and low-enriched uranium to utilities. Its backlog surged to $4.5bn extending through 2040, with $2.4bn of enrichment work moved from contingent to definitive agreements. It was awarded a $900m firm-fixed-price DOE task order to build commercial high-assay low-enriched uranium (HALEU) capacity at Piketon, Ohio.

The income statement disagrees. Gross margin fell to 28.3% from 34.9% and operating income fell 69%, as enrichment cost of sales rose 36% while volumes fell 23%. Consensus 2026 earnings of $2.56 per share sit 43% below last year's $3.90. Its forward multiple of 74.3x is barely below the 75.8x trailing — the growth is in the contracts, not yet the profits. Centrus is the only one of the nine whose 50-day average has begun to repair against its 200-day, on 12 August.

The four with no revenue

Oklo, designer of the Aurora powerhouse, booked $1.21m of revenue against a $73.2m quarterly operating loss; its Groves isotope reactor reached first criticality in under 11 months from groundbreaking. It holds $3bn of cash against a $7.72bn market value, meaning roughly $4.7bn is being paid for the plan. NuScale Power, the only SMR designer with NRC design certification, saw revenue collapse to $75,000 as engineering work for Romania's RoPower finished; it trades at 0.75x book, the only one of the nine below it, with $1.9bn of cash against $2.80bn of value, and its Tennessee Valley Authority discussions have no signed power contract. Nano Nuclear Energy, 36 employees and four microreactor designs, booked $214,042 of quarterly revenue at 888x forward sales. Lightbridge, a 13-person metallic-fuel developer, has reported zero revenue in each of the last five fiscal years and holds $237.5m of cash against $297m of market value; its HALEU arrangement with Centrus is explicitly non-binding.

The two smaller miners sit in between. Uranium Energy Corp reported no revenue at all in the quarter to 30 April with a $40.8m operating loss, and consensus has fiscal-2026 revenue falling 59% to $26.9m. Energy Fuels, which runs the White Mesa mill in Utah, grew revenue nearly sixfold to $25.1m at a 57.4% gross margin — and still lost $33.4m.

The setup

Where it stands — One company in this group raised guidance and grew backlog 40%; it is the one that fell. Would confirm — BWXT holding book-to-bill above 1.0x with commercial-segment margin recovering toward 14% in 2027. Would invalidate — Backlog growth stalling or 2026 revenue landing below the roughly $3.8bn guided. Watch next — BWXT's third-quarter results, due early November, and the Westinghouse IPO pricing. Valuation — BWXT at 44.6x trailing and 36.5x forward earnings, 4.19x forward sales against roughly 5x in May.

The American restaurant industry is losing customers. Guest counts nationwide fell 4% in July from a year earlier, the weakest reading since 2017 and the fifteenth year-on-year decline in sixteen months, with same-store sales down 1%. Industry data also show about 9% of full-service restaurants losing 30% or more from peak sales, a level associated with closure.

Most of the publicly traded sit-down chains reported the reverse last quarter. That is the finding: this is share being taken from somebody, not a consumer coming back.

Guests, not just menu prices

Brinker International, which operates Chili's Grill & Bar and Maggiano's Little Italy across roughly 1,650 restaurants, said Chili's comparable sales rose 5.6% in the quarter ended in June — 4.3 points of menu pricing, but 1.5 points of actual traffic. It was the fifth straight year of Chili's same-store growth, a cumulative 71%.

BJ's Restaurants, a 213-unit chain of pizza-and-craft-beer restaurants built around its Pizookie dessert, reported 8.3% more guests, its eighth consecutive quarter of traffic growth. Cheesecake Factory, which runs 306 restaurants including its namesake chain, North Italia and Flower Child plus two bakeries, grew traffic 2.7% at the flagship brand. Steak 'n Shake, owned by the conglomerate Biglari Holdings, posted 11.9% domestic same-store sales.

What the guests cost

BJ's average check fell 1.8%. Discount-led traffic works only if the kitchen absorbs it, and BJ's restaurant-level margin did expand, to 17.2% against a commodity basket up roughly 5% and beef up 20%. Management raised full-year comparable sales guidance to 3%-4% from 1%-3%.

Further down the income statement it stops working. BJ's operating income fell 9.1% and net income 15.4% on revenue growth of 6.4%; operating margin narrowed to 5.01% from 5.86%. Beef is the binding constraint industry-wide: US prices reached a record $6.90 a pound by May, with meat costs up 32% over two years against menu burger prices up 14%.

Cheesecake converted better. Revenue rose 7.7% to $1.03bn, the first quarter above $1bn in its history, and operating margin widened 85 basis points to 7.63%. Restaurant-level margin of 20% was its best in a decade. Not everything works: North Italia comps fell 3% and its margin dropped to 15.6% from 18.2%. Brinker converted best of all — fiscal 2026 revenue up 7.9% to $5.81bn, net income up 27.1% to $487m, and Chili's restaurant expense ratio down to 81.4% from 81.8%.

Darden, the group's largest at 1,870 restaurants including Olive Garden, LongHorn Steakhouse and The Capital Grille, is following rather than leading. Fiscal 2026 revenue grew 9.4% to $13.21bn, but Olive Garden comps rose only 2.4% against a 3.2% expectation while LongHorn rose 9.5%. Its fiscal 2027 guide of 2.5%-3.5% same-restaurant sales is a deceleration, accompanied by an 8% dividend increase and a new $1.5bn buyback.

The one that isn't working

Cracker Barrel, the roadside chain pairing country cooking with retail gift shops, diverges from all of it. Revenue has fallen year on year for three straight quarters, by 5.7%, 7.9% and 2.9%. Second-quarter traffic fell about 10%, its steepest since a botched rebrand, and management's own fiscal 2026 plan assumes traffic of -4% to -7%. Consensus for fiscal 2026 is a loss of four cents a share. The shares doubled in three months and remain down 7.4% over a year — a turnaround being paid for in advance.

Biglari Holdings is not really a restaurant multiple. Its quarter produced $39.9m of net income, of which $35.6m came from investment-partnership gains against $9.7m from the operating businesses. Chairman Sardar Biglari is separately an activist in Cracker Barrel, linking two names here.

What the prices assume

Brinker trades at 18.9x forward earnings and 14.0x trailing EV/EBITDA, with a 5.5% free-cash-flow yield; Darden at 20.0x and 13.5x. Texas Roadhouse, the nearest listed peer, trades at 32.2x forward and 18.9x — and shows what the squeeze looks like when a chain does not escape it: revenue rose 11.1% last quarter while operating income fell 2.4%. Cheesecake's trailing multiple went from roughly 17x in mid-May to about 30x now, a doubling of the multiple on single-digit revenue growth. BJ's is 28.7x forward on falling profit. Cracker Barrel is the only name whose forward multiple, 52.6x, exceeds its trailing 49.2x.

The move itself is concentrated. Strip each name's two largest sessions — Cheesecake's 11.4% jump on 29 July and Brinker's 9.6% on 12 August among them — and the month's average gain drops from 18.8% to 5.6%. Four of six remain positive after that strip, so the advance is narrow rather than manufactured. All six sit near the top of their traded range.

The setup

Where it stands — Five of six chains grew guest counts while national restaurant traffic fell to its weakest since 2017. Would confirm — Chili's and BJ's report positive traffic again next quarter while the industry benchmark stays negative. Would invalidate — BJ's restaurant-level margin falls below 17% as check declines deepen, or Brinker's fiscal 2027 comps miss 5%. Watch next — Darden's fiscal first-quarter report in September; Cracker Barrel's fiscal fourth quarter, guided to traffic of -4% to -7%. Valuation — Brinker 21.3x trailing and 18.9x forward, Darden 21.5x and 20.0x, both under Texas Roadhouse's 33.1x and 32.2x.

Accenture told investors in June that it would grow 3% to 4% this fiscal year in local currency, trimming its earlier plan. Infosys cut its outlook on 23 July. EPAM cut on 6 August. Globant cut on 13 August. Four of the eight largest listed enterprise-consulting and systems-integration firms lowered full-year revenue guidance inside a five-week window — and across that same window their shares rose an average of 20%.

These are the labor-arbitrage businesses the market spent the past year pricing as the first casualty of AI that writes its own code: firms paid per consultant-hour, per managed-services contract and per offshore delivery seat. Over twelve months the group is still down roughly a quarter.

Four days did the work

Seven of the eight recorded their single largest session of the month between 27 and 30 July. Cognizant gained 16.5% and Infosys 13.0% on 28 July; Globant added 17.4% and EPAM 12.8% on 29 July. Two things happened in that window. Chip stocks shed more than $1trn of market value as investors questioned record AI capital spending, and Jefferies lifted Indian IT from underweight to neutral on 27 July, citing a possible reversal in the AI trade and foreign funds rethinking crowded underweights — while still forecasting only low-to-mid single-digit revenue growth through fiscal 2028. India's Nifty IT index gained nearly 16% in July. The move was not specific to these eight: DXC rose 11.8% on 27 July and IBM 10.6% on 28 July.

Zero out each name's two biggest sessions and the group average of 20.1% becomes 0.3%. The median member turns to roughly -4.7%. Only Accenture, Cognizant and Grid Dynamics keep a gain.

The funding trade has since reversed completely. From 29 July to 14 August Nvidia rose 18.5% and Micron 31.5%, and the S&P 500 tracker sits above its mid-July level. The consultants stalled: five of the eight are lower over that stretch, with EPAM down 5.4% and Infosys 4.0%.

Three businesses got better

Cognizant, the Teaneck, New Jersey outsourcing firm with 356,700 employees, is the clearest confirmation. It raised full-year adjusted earnings guidance to $5.70-$5.82 a share, grew trailing bookings 5% to $29bn, signed seven contracts above $100m and posted a sixth straight quarter of adjusted margin expansion, at 16.0%. Its financial-services vertical grew 12%. The shares rose 11.3% on the print. Management still flagged that one in four Global 2000 companies have paused AI deployments.

CGI, the Montreal IT and business-process provider, carried the best order book: $17.8bn of trailing bookings at a 108% book-to-bill, $31.8bn of contracted backlog, and hiring up 50% year on year. Organic growth, though, was roughly flat once acquisitions are removed.

Grid Dynamics, a San Ramon, California engineering firm of 4,838 people, disclosed the largest quantified AI mix in the group: 30.7% of revenue, growing 54.6%, with gross margin at 36.6% against 34.1%. Its operating income was $1.28m on $108.2m of revenue.

Five did not

Accenture, the Dublin-headquartered professional-services firm with 799,000 employees, reported fiscal third-quarter new bookings of $19.32bn, down 3% in local currency. Its July gain of roughly 33% was attributed to rotation, a defense contract and a larger buyback, not new demand.

Infosys, the Bengaluru group behind the Finacle banking platform, made the most consequential admission: clients now demand price cuts at renewal and increasingly mid-contract, which management called "deflation" and did not quantify. Its guidance implies barely 0.5% organic growth. AI-first work reached 8.2% of revenue.

EPAM, the Newtown, Pennsylvania software-engineering firm, beat on earnings and fell more than 20%: Americas revenue, 57% of the total, grew 0.5%, and it pushed its agentic managed-services revenue into the first half of 2027. Globant, the Luxembourg-domiciled AI-studio firm, cut guidance on project delays and travel-client weakness with revenue flat at $614.4m; its AI Pods subscription reached $52.8m of annualized revenue, about 2% of the total. Wipro's rupee revenue rose 11.2%, but its dollar IT-services revenue was flat and its margin fell 120 basis points.

What the prices assume

After the month, the multiples still sit well below their own history. Accenture trades at 14.0x trailing and 12.8x forward earnings, against roughly 21x a year ago and about 30x two years ago, with an 11.6% free-cash-flow yield. Cognizant is at 10.2x forward, below the 14-15x it fetched in May. Globant is the extreme at 6.0x forward and 0.76x book.

Infosys is the exception and the warning. Its forward multiple, 15.2x, sits above its trailing 14.9x — consensus expects earnings to go backwards. It rallied 9.5% while cutting guidance.

The trend measures underneath have been upgraded twice since late July, but none of the eight has its 50-day average back above its 200-day. Accenture, Cognizant and Infosys remain mildly negative; the other five are neutral.

The setup

Where it stands — A four-day rotation out of AI chips lifted the group 20%; the underlying order books improved at three of eight names. Would confirm — Accenture's fiscal fourth-quarter new bookings returning to year-on-year growth from -3%. Would invalidate — A fifth full-year guidance cut, or Cognizant's trailing bookings growth slipping below 5%. Watch next — Accenture reports fiscal fourth-quarter results and first fiscal-2027 guidance in late September. Valuation — Accenture at 14.0x trailing and 12.8x forward earnings, against roughly 21x in August 2025 and 30x in August 2024.

Enterprise software spent the first half of 2026 being priced as a casualty of artificial intelligence. The argument was simple: if AI agents do the work that software licenses used to do, seat counts fall and revenue follows. Investors sold the sector hard enough that the episode acquired a nickname on this desk's own reading — the SaaSpocalypse. Then, from mid-February, they bought it back.

Seven companies at the intersection of software and the data-center buildout have risen a median 80% over six months: ServiceNow, which sells the workflow platform large enterprises run IT, HR and customer-service processes on; Datadog, which monitors cloud applications and bills by host and by log ingested; Cloudflare, which runs a global edge network selling security, content delivery and serverless compute; Snowflake, which sells data warehousing by the consumption credit; and three security names — Palo Alto Networks in firewalls, Okta in identity, Rubrik in backup and cyber-recovery. The S&P 500 rose 13.9% over the same stretch.

The businesses did not do that. Trailing gross profit — revenue less the cost of delivering the service, and the cleanest measure of scale when four of the seven report negative earnings — grew a median 13% over those six months. The best performer on that measure was Rubrik, at 21.1%. Every one of the seven now costs more per dollar of gross profit than it did in February: roughly 8% more at ServiceNow, 43% at Cloudflare, 55% at Rubrik, 57% at Snowflake, 59% at Okta, 77% at Datadog and 119% at Palo Alto.

What actually got better

Four of the seven have real operating news behind them. ServiceNow's revenue growth accelerated four quarters running, from 20.7% to 24.0%, reaching $3.99bn in the June quarter. Contracted revenue due within twelve months reached $13.2bn, up 21%, with subscription revenue 150 basis points above guidance, on a 98% renewal rate; annual contract value from AI products crossed $1bn. Yet management raised the full-year subscription guide by only $15m, to $15.770bn, and said roughly half the beat was an on-premise pull-forward from the third quarter. Gross margin fell to 70.7% from 77.5% a year earlier as the Moveworks and Armis acquisitions consolidated.

Datadog grew 35.6%, its fastest since 2022, with net revenue retention in the low 120s and free cash flow of $279m at a 25% margin. It then fell about 19% in one session on 6 August after disclosing that its largest AI customer renewed a nine-figure contract but will cut usage from the third quarter, taking guided growth down to 28-29%. That is consumption billing working in reverse.

Cloudflare accelerated from 30.7% to 35.9% and reported dollar-based net retention of 120%, up six points year on year, with remaining performance obligations up 38% and the full-year guide raised to about $2.87bn. It is also the most expensive name here, at 61.4x trailing gross profit and a 0.34% free-cash-flow yield.

Snowflake re-accelerated to 33.5% growth on $1.39bn of revenue — in a quarter reported on 27 May. It has published nothing since, while analysts raised targets through early August. Its operating margin is -23.4%.

Where the numbers don't follow

Palo Alto's headline 31.1% revenue growth in its April quarter came after three quarters near 15%, and gross profit rose only 21.5% as gross margin fell to 67.6% from 72.9%; operating income swung to -$183m. The step-change is acquisition arithmetic, not organic re-acceleration. The shares hit records after the Black Hat conference in August, and the company does not report again until 1 September.

Okta is decelerating — 12.7% to 11.2% across four quarters — and has guided the current fiscal year to 9-10% growth, its slowest since listing. It is the cheapest of the seven at 10.6x trailing gross profit, with a 3.7% free-cash-flow yield and expanding gross margin. Rubrik has slowed for four straight quarters, from 51.2% to 39.0%, though its operating margin improved to -13.6%; it has reported nothing since 4 June and is nonetheless the largest gainer of the past month.

The single session that carried the month

On 4 August all seven rose together, an average of 5.24% in one day — roughly 40% of the group's entire thirty-day gain. That was a market-wide rally that took the S&P 500 to a record, up 1.79%, with the main software exchange-traded fund adding nearly 5%. Strip that session out and Okta is down about 6% over the month and Palo Alto up about 3%.

The uptrends are also younger than they look. Cloudflare has held its 50-day average above its 200-day since 5 May, 68 trading sessions. ServiceNow only crossed on 12 August, after 148 consecutive sessions in a downtrend that ran from late October to May — and it remains the only one of the seven lower than a year ago, down 27%.

The setup

Where it stands — Seven software names have re-rated a median 80% in six months on gross profit that grew about 13%. Would confirm — Snowflake, Okta and Palo Alto printing revenue growth at or above their last reported rates in the next three weeks. Would invalidate — Datadog's third-quarter growth landing below the guided 28-29%, or Okta's fiscal-year guide staying at 9-10%. Watch next — Snowflake reports 25 August, Okta 26 August, Palo Alto Networks 1 September. Valuation — Price to trailing gross profit spans 10.6x at Okta to 61.4x at Cloudflare; forward sits below trailing for all seven.

Salesforce, whose cloud software runs the sales pipelines, service desks and marketing campaigns of much of corporate America, is growing faster than it was a year ago. Revenue in the April quarter rose 13.3% to $11.13bn — the third consecutive quarter of acceleration, from 8.6% in the October quarter and 12.1% in January. Operating margin widened to 21.8% from 19.8%, which turned that revenue growth into a 25% gain in operating income. The company also retired roughly a tenth of itself: diluted shares fell from 970m to 871m over twelve months.

The share price has said something else entirely. Salesforce's 50-day average has been below its 200-day every session since 23 January — 145 trading days, including an unbroken stretch from late January to June — and the stock is down 15.9% over twelve months, sitting about 27% below its high near $269.

What the market is arguing

The bear case is structural rather than financial. Salesforce bills largely by the seat, and the fear that AI agents will do the work those seats pay for has taken roughly $2 trillion out of software-sector value since early 2026. Salesforce is a system of engagement, not infrastructure — the layer where humans type, which is precisely the layer an agent can bypass. Klarna's public abandonment of Salesforce for an AI-assembled stack gave the argument a name to point at.

The company's answer is that it sells the agents too. Agentforce and its Data 360 platform reached about $1.4bn of combined annual recurring revenue, up 114%, across more than 9,500 paid deals, against current remaining performance obligations of $29.4bn, up 11%. Salesforce is now pushing a flat-rate "Agentic Enterprise License Agreement" that removes per-consumption friction — read by bulls as land-then-expand and by bears as capping the monetisation.

On price, the stock is the second-cheapest of the nine on forward price per dollar of gross profit at 4.49x, behind only BILL, the accounts-payable automation vendor, at 3.32x. It trades at 13.86x forward earnings against 22.63x trailing, and its 9.12% trailing free-cash-flow yield is the highest of the group. Notably, that multiple has barely moved: 4.60x price-to-gross-profit in early May, 4.83x now, while gross profit grew 13.2%. The year's price damage was done before this spring; the recovery since has been earned by the numbers rather than paid for by a re-rating. JPMorgan initiated coverage on 13 August with an Overweight rating and a $250 target, calling the disruption fear overblown.

The honest caveat is that consensus already discounts the acceleration: analysts model FY2028 revenue growth of 9.4% and earnings growth of 10.4%, slower than what the company is doing now. The 26 August second-quarter report is the test, and UBS has warned the bar is high after the recent bounce.

JFrog: the best quarter, the worst price

JFrog runs Artifactory, the repository where enterprises store and version every binary, container and package that passes through a software build pipeline — plumbing an AI coding assistant needs rather than replaces. Its June quarter was the strongest in the group: revenue up 28.7% to $163.8m and accelerating, cloud revenue up 53% to a majority of the mix, net dollar retention of 121%, remaining performance obligations up 38% to $659m, and full-year guidance raised to $648–652m. Customers spending over $1m a year grew to 97 from 61.

And the shares have run past all of it. Price per dollar of trailing gross profit has gone from 13.50x in early May to 21.21x in late July to 24.93x now — an 85% expansion in fifteen weeks that took market value from $5.51bn to $11.65bn. At 23.64x forward gross profit, JFrog is dearer than the next-most-expensive name, fleet-tracking vendor Samsara at 14.98x, by more than half again, and more than five times Salesforce. It is still loss-making on a reported basis, carries a 1.46% free-cash-flow yield, and issued 5.7% more shares over the year — the exact opposite of Salesforce's buyback. Management also notes that 47% of revenue is still on-premises and grew only 9%.

One mechanical point worth clearing: JFrog's trend signal stepped down on 13 August, a session in which the stock rose 7.9%. That is a lagging average catching up, not weakness; the shares sit 3.1% below their 52-week high.

The month was three days and two names

The nine names returned 21.1% on average over thirty days. Strip out Atlassian and Veeva and that falls to 12.4%; Atlassian alone accounts for two-fifths of it. Three sessions — 28 July, 7 August and 13 August — compound to more than the entire month, meaning the other eighteen were net negative. The 28 July move was a rotation out of chipmakers into oversold enterprise software, not news.

The leaders are uneven. Atlassian, which sells the Jira and Confluence project-tracking tools, grew 28% in its June quarter and beat consensus — then guided to 13% growth for the coming year, half what it just delivered, and rose 35% anyway. Veeva, which sells clinical-trial and commercial software to drugmakers, gained 25.9% without reporting at all. Nutanix, in private-cloud infrastructure, gained 22% while revenue growth decelerated to 10.0% and it announced a cut of about 5% of staff on 4 August. Twilio, the messaging-API provider, raised organic growth guidance to 13–13.5%, but its 48.4% gross margin means it is the group's third-dearest name once you price gross profit rather than sales. Dynatrace, in application monitoring, is the steady one: recurring revenue up 17%, a 29% adjusted operating margin, $275m of buybacks in a quarter. Samsara grew fastest of all at 30.5% and earns almost nothing on it, at a 1.5% reported operating margin.

Ranked by cash generated per dollar of price, the order inverts the ranking by share-price performance: Salesforce first at 9.12%, BILL second, Samsara and JFrog last.

The setup

Where it stands — Salesforce's growth and margins have improved for three quarters while its shares have traded below trend since January. Would confirm — Second-quarter revenue growth on 26 August holding at or above 13%, with current remaining performance obligations still growing double digits. Would invalidate — Growth falling back below 11%, or full-year guidance trimmed, which would make the year-long derating earned. Watch next — Salesforce fiscal second-quarter results, 26 August 2026. Valuation — 13.86x forward earnings against 22.63x trailing; 4.49x forward gross profit, versus JFrog's 23.64x and BILL's 3.32x.

The contract price of conventional computer memory rose 90% to 95% in the first quarter of this year, with another 58% to 63% expected in the second, as memory makers steered capacity toward high-bandwidth memory for artificial-intelligence accelerators, which carries margins three to five times higher. Someone in the server supply chain has to absorb that. The conventional answer is that the branded manufacturer passes it to the customer, and the contract assemblers paid a few points of margin per rack eat it.

Last quarter it ran the other way.

Dell Technologies, which builds servers, storage and PCs and sells them directly to enterprises, governments and cloud operators, reported fiscal first-quarter revenue of $43.8bn, up 87.5% from a year earlier. Gross margin fell to 17.75% from 21.12% — a 337 basis-point compression. Operating income nearly tripled anyway, up 196.8%, because the volume covered fixed costs and operating margin widened from 5.27% to 8.34%. That is operating leverage doing the work, not pricing.

Celestica, a Toronto-based builder of switches, interconnects and custom server racks for hyperscale data-center operators, grew June-quarter revenue 62.4% to $4.70bn with gross margin down just 53 basis points, to 12.29%. Flex, a contract manufacturer whose fastest-growing line is data-center power distribution gear, grew fiscal first-quarter revenue 20.6% to $7.93bn — and its gross margin rose 72 basis points, to 9.42%.

Both beat, both raised, both fell

Celestica lifted full-year revenue guidance to $20.5bn from $19bn and adjusted earnings to $11.30 a share from $10.15. On its July call it disclosed two programs with multi-billion-dollar 2027 potential — custom racks for OpenAI using a Broadcom accelerator, and a design and manufacturing role on AMD's Helios interconnect — plus ten 1.6-terabit programs ramping in the second half.

Flex raised fiscal 2027 revenue guidance to $33.7-35.2bn and adjusted earnings to $4.42-4.74 a share, reported record adjusted earnings of $1.00 against a $0.90 consensus, and said roughly 90% of the next three quarters is already booked.

What broke was cash. Celestica priced a $3bn share sale on 5 August at $310, below the prior close, to fund working capital and capacity; the stock fell 14.8% the following session. Its capital spending hit 5.6% of revenue last quarter against 1.1% a year earlier, is guided to $1bn this year with a $1.5bn placeholder for next, and its trailing free-cash-flow yield is 1.35%. Flex converted $534m of adjusted operating profit into $41m of free cash flow and cut conversion guidance to roughly 40% from 60%; it fell 9.1% on its earnings day. Both were also caught in the broad hardware selloff after Alphabet guided 2026 capital spending to $195-205bn and posted a negative free-cash-flow quarter, which chip investors read as a warning rather than a commitment.

What each is now priced at

Dell's price per dollar of trailing gross profit was 6.99x on 18 May and is 12.77x today, an 83% re-rating in three months; its forward earnings multiple went from about 19x to 26.58x, against a trailing 38.37x. Its own news supports part of that — an AI server backlog of $51.3bn and a fiscal 2027 AI server target lifted to about $60bn — but the largest single day of the advance was not its own: shares rose about 10% on 12 August after Super Micro Computer guided fiscal 2027 revenue far above consensus.

Celestica's price per dollar of gross profit fell to 21.29x from 26.26x over the same stretch, and its trailing earnings multiple to 34.47x from about 46x, while guidance went up. On consensus 2028 earnings of $26.68, it sits near 12.6x. Flex's fell to 16.79x from 21.42x; its forward multiple of 26.85x against a trailing 48.71x is the widest gap of the three, and on 2028 consensus earnings of $7.12 it sits near 17.7x. Flex also plans to spin off its cloud and power infrastructure business, tax-free, in the first quarter of calendar 2027 — a separation consolidated multiples do not yet price.

The charts agree with none of this. Dell's 50-day average has sat above its 200-day for 92 straight sessions since 31 March, after a bearish crossing as recently as early March, and it closed 14 August within 1% of its highest price since June. Celestica's crossed the other way on 12 August, leaving it 29.1% below its June peak; Flex's trend weakened on 17 July and it is 22.2% off its own.

The demand backdrop has not deteriorated: Bank of America expects hyperscaler capital spending above $1.2trn over the next twelve months. The question the two contract manufacturers now pose is whether growth they must pre-fund with equity and factories is worth less than growth Dell books against a balance sheet it already owns.

The setup

Where it stands — Dell has doubled since mid-May while Celestica and Flex, both of which beat and raised, have fallen. Would confirm — Celestica delivering its guided $600m of 2026 free cash flow, and Flex conversion recovering above 40%. Would invalidate — Dell's fiscal Q2 gross margin stabilizing near 17.75% with backlog above $51.3bn while the pair miss again. Watch next — Dell reports fiscal second-quarter results on 3 September. Valuation — Dell 38.37x trailing and 26.58x forward earnings; Celestica 34.47x and 29.46x; Flex 48.71x and 26.85x.